$MSTX Company News Adventrx seeks FDA meeting
Post# of 145152
Posted On: 11/02/2014 11:35:07 AM
$MSTX Company News
Adventrx seeks FDA meeting for pipeline products 8:15 a.m. Aug. 30, 2011 - MarketWatch.com
Icahn reports new stakes in Vector Group, El Paso 6:52 p.m. Aug. 15, 2011 - MarketWatch.com
Adventrx plunges 57% on FDA setback 2:17 p.m. Aug. 10, 2011 - Val Brickates Kennedy
Wednesday’s biggest gaining & declining stocks 12:40 p.m. Aug. 10, 2011 - Kate Gibson
Affymax rallies; drug indexes dip 1:08 p.m. Jan. 7, 2011 - Val Brickates Kennedy
Thursday’s biggest gaining and declining stocks 4:45 p.m. Jan. 6, 2011 - Kate Gibson
Adventrx climbs on FDA update 11:12 a.m. Jan. 6, 2011 - Val Brickates Kennedy
10-Q: MAST THERAPEUTICS, INC. 3:18 p.m. Oct. 31, 2014 - Edgar Online - (EDG = 10Q, 10K)
Why Imminent Orphan Status Designation Will Attract Big Pharma To Mast Therapeutics 9:45 a.m. Oct. 1, 2014 - Seeking Alpha
Mast Therapeutics reports clinical results for PAH product candidate 9:02 a.m. Sept. 8, 2014 - Seeking Alpha
Biotech Stocks 101 — What Investors Need to Know 5:59 a.m. Aug. 29, 2014 - InvestorPlace.com
Mast Therapeutics' MST-188 Would Fit Well In Merck's Drug Development Pipeline 9:19 a.m. June 24, 2014 - Seeking Alpha
Interesting MSTX Put And Call Options For January 2015 11:39 a.m. May 19, 2014 - TheStreet.com
10-Q: MAST THERAPEUTICS, INC. 3:43 p.m. May 5, 2014 - Edgar Online - (EDG = 10Q, 10K)
10-K: MAST THERAPEUTICS, INC. 7:48 a.m. March 26, 2014 - Edgar Online - (EDG = 10Q, 10K)
The Bull Case For Mast Therapeutics Just Got Even Brighter With Its Recent Acquisition 7:15 a.m. Feb. 12, 2014 - Seeking Alpha
Mast Therapeutics to buy blood-pressure firm Aires 9:36 a.m. Feb. 10, 2014 - Seeking Alpha
Mast Pharmaceuticals Inc.: Breakthrough Drug MST-188 Could Lead To Huge Gains 7:14 a.m. Jan. 21, 2014 - Seeking Alpha
Mast Therapeutics posts enormous gain 4:04 p.m. Jan. 13, 2014 - Seeking Alpha
GlycoMimetics IPO Kicks Off 2014 IPO Action 12:51 p.m. Jan. 9, 2014 - Seeking Alpha
Mast Therapeutics rallies on heart failure data 8:51 a.m. Jan. 6, 2014 - Seeking Alpha
Mast Therapeutics rallies on heat failure data 8:51 a.m. Jan. 6, 2014 - Seeking Alpha
Mast Therapeutics: A Hidden Gem In An Under-served Market 2:05 p.m. Nov. 18, 2013 - Seeking Alpha
Glycomimetics IPO Is Risky But Promising 8:20 p.m. Nov. 6, 2013 - Seeking Alpha
10-Q: MAST THERAPEUTICS, INC. 4:11 p.m. Nov. 4, 2013 - Edgar Online - (EDG = 10Q, 10K)
2 Bold Speculative Plays In Biotech With Major Upside 8:13 a.m. Oct. 6, 2013 - Seeking Alpha
3 Micro-Caps With Sustainable Cash Flows 11:39 a.m. Feb. 13, 2013 - Seeking Alpha
Mast Therapeutics Reports Third Quarter 2014 Financial Results 7:00 a.m. Oct. 31, 2014 - PR Newswire - PRF
Mast Therapeutics Announces Appointment Of Chief Medical Officer 7:00 a.m. Oct. 2, 2014 - PR Newswire - PRF
Mast Therapeutics Announces Positive Top Line Results From Phase 2 Study Of AIR001 For Pulmonary Arterial Hypertension And AIR001 Clinical Development Plan 7:00 a.m. Sept. 8, 2014 - PR Newswire - PRF
Mast Therapeutics To Present At The Rodman And Renshaw 16th Annual Global Investment Conference On September 9th 7:00 a.m. Sept. 2, 2014 - PR Newswire - PRF
Mast Therapeutics Announces Management Change 3:05 p.m. Aug. 29, 2014 - PR Newswire - PRF
Technical Recap on Biotech Equities -- CytRx, AVEO Pharma, Mast Therapeutics, Immunomedics, and Dynavax Technologies 8:00 a.m. Aug. 8, 2014 - PR Newswire - PRF
Mast Therapeutics To Present At The Canaccord Genuity 34th Annual Growth Conference On August 14th 7:00 a.m. Aug. 7, 2014 - PR Newswire - PRF
Mast Announces Appointment Of Howard C. Dittrich M.D. To Board of Directors 3:15 p.m. June 19, 2014 - PR Newswire - PRF
Mast Therapeutics Initiates Sub-Study Within Phase 3 EPIC Trial 7:00 a.m. June 16, 2014 - PR Newswire - PRF
Technical Coverage on Active Stocks -- Research on Mast Therapeutics, North American Palladium, KeyCorp, and Synovus Financial 7:30 a.m. May 30, 2014 - PR Newswire - PRF
AmpliPhi Announces Appointment of New Board Member 3:16 p.m. May 22, 2014 - BusinessWire - BZX
Biotech Equities Under Review -- Research on Achillion Pharma, Mast Therapeutics, Alkermes, and Momenta Pharma 12:30 p.m. May 9, 2014 - PR Newswire - PRF
Mast Therapeutics Reports First Quarter 2014 Financial Results 7:00 a.m. May 5, 2014 - PR Newswire - PRF
Biotech Stocks Review -- Research on Achillion Pharma, Medivation, Mast Therapeutics, and Athersys 7:16 a.m. April 14, 2014 - PR Newswire - PRF
Mast Therapeutics Announces New Data Supporting MST-188 In Sickle Cell Disease 7:00 a.m. April 14, 2014 - PR Newswire - PRF
Mast Therapeutics Reports Fourth Quarter And Full Year 2013 Financial Results 7:15 a.m. March 26, 2014 - PR Newswire - PRF
Mast Therapeutics Initiates Phase 2 Study Of MST-188 In Patients With Acute Limb Ischemia 7:00 a.m. March 26, 2014 - PR Newswire - PRF
Active Stocks Coverage -- Research on Starbucks, Gerdau, Mast Therapeutics and Cia de Saneamento Basico do Estado 9:28 a.m. March 21, 2014 - PR Newswire - PRF
Purified Poloxamer Granted Unique Nonproprietary Name (Vepoloxamer) By U.S. Adopted Names Council 7:00 a.m. March 11, 2014 - PR Newswire - PRF
Vista Partners Publishes March 2014 Macroeconomic & Investment Newsletter 9:01 a.m. March 7, 2014 - Marketwire
Adventrx seeks FDA meeting for pipeline products 8:15 a.m. Aug. 30, 2011 - MarketWatch.com
Icahn reports new stakes in Vector Group, El Paso 6:52 p.m. Aug. 15, 2011 - MarketWatch.com
Adventrx plunges 57% on FDA setback 2:17 p.m. Aug. 10, 2011 - Val Brickates Kennedy
Wednesday’s biggest gaining & declining stocks 12:40 p.m. Aug. 10, 2011 - Kate Gibson
Affymax rallies; drug indexes dip 1:08 p.m. Jan. 7, 2011 - Val Brickates Kennedy
Thursday’s biggest gaining and declining stocks 4:45 p.m. Jan. 6, 2011 - Kate Gibson
Adventrx climbs on FDA update 11:12 a.m. Jan. 6, 2011 - Val Brickates Kennedy
10-Q: MAST THERAPEUTICS, INC. 3:18 p.m. Oct. 31, 2014 - Edgar Online - (EDG = 10Q, 10K)
Why Imminent Orphan Status Designation Will Attract Big Pharma To Mast Therapeutics 9:45 a.m. Oct. 1, 2014 - Seeking Alpha
Mast Therapeutics reports clinical results for PAH product candidate 9:02 a.m. Sept. 8, 2014 - Seeking Alpha
Biotech Stocks 101 — What Investors Need to Know 5:59 a.m. Aug. 29, 2014 - InvestorPlace.com
Mast Therapeutics' MST-188 Would Fit Well In Merck's Drug Development Pipeline 9:19 a.m. June 24, 2014 - Seeking Alpha
Interesting MSTX Put And Call Options For January 2015 11:39 a.m. May 19, 2014 - TheStreet.com
10-Q: MAST THERAPEUTICS, INC. 3:43 p.m. May 5, 2014 - Edgar Online - (EDG = 10Q, 10K)
10-K: MAST THERAPEUTICS, INC. 7:48 a.m. March 26, 2014 - Edgar Online - (EDG = 10Q, 10K)
The Bull Case For Mast Therapeutics Just Got Even Brighter With Its Recent Acquisition 7:15 a.m. Feb. 12, 2014 - Seeking Alpha
Mast Therapeutics to buy blood-pressure firm Aires 9:36 a.m. Feb. 10, 2014 - Seeking Alpha
Mast Pharmaceuticals Inc.: Breakthrough Drug MST-188 Could Lead To Huge Gains 7:14 a.m. Jan. 21, 2014 - Seeking Alpha
Mast Therapeutics posts enormous gain 4:04 p.m. Jan. 13, 2014 - Seeking Alpha
GlycoMimetics IPO Kicks Off 2014 IPO Action 12:51 p.m. Jan. 9, 2014 - Seeking Alpha
Mast Therapeutics rallies on heart failure data 8:51 a.m. Jan. 6, 2014 - Seeking Alpha
Mast Therapeutics rallies on heat failure data 8:51 a.m. Jan. 6, 2014 - Seeking Alpha
Mast Therapeutics: A Hidden Gem In An Under-served Market 2:05 p.m. Nov. 18, 2013 - Seeking Alpha
Glycomimetics IPO Is Risky But Promising 8:20 p.m. Nov. 6, 2013 - Seeking Alpha
10-Q: MAST THERAPEUTICS, INC. 4:11 p.m. Nov. 4, 2013 - Edgar Online - (EDG = 10Q, 10K)
2 Bold Speculative Plays In Biotech With Major Upside 8:13 a.m. Oct. 6, 2013 - Seeking Alpha
3 Micro-Caps With Sustainable Cash Flows 11:39 a.m. Feb. 13, 2013 - Seeking Alpha
Mast Therapeutics Reports Third Quarter 2014 Financial Results 7:00 a.m. Oct. 31, 2014 - PR Newswire - PRF
Mast Therapeutics Announces Appointment Of Chief Medical Officer 7:00 a.m. Oct. 2, 2014 - PR Newswire - PRF
Mast Therapeutics Announces Positive Top Line Results From Phase 2 Study Of AIR001 For Pulmonary Arterial Hypertension And AIR001 Clinical Development Plan 7:00 a.m. Sept. 8, 2014 - PR Newswire - PRF
Mast Therapeutics To Present At The Rodman And Renshaw 16th Annual Global Investment Conference On September 9th 7:00 a.m. Sept. 2, 2014 - PR Newswire - PRF
Mast Therapeutics Announces Management Change 3:05 p.m. Aug. 29, 2014 - PR Newswire - PRF
Technical Recap on Biotech Equities -- CytRx, AVEO Pharma, Mast Therapeutics, Immunomedics, and Dynavax Technologies 8:00 a.m. Aug. 8, 2014 - PR Newswire - PRF
Mast Therapeutics To Present At The Canaccord Genuity 34th Annual Growth Conference On August 14th 7:00 a.m. Aug. 7, 2014 - PR Newswire - PRF
Mast Announces Appointment Of Howard C. Dittrich M.D. To Board of Directors 3:15 p.m. June 19, 2014 - PR Newswire - PRF
Mast Therapeutics Initiates Sub-Study Within Phase 3 EPIC Trial 7:00 a.m. June 16, 2014 - PR Newswire - PRF
Technical Coverage on Active Stocks -- Research on Mast Therapeutics, North American Palladium, KeyCorp, and Synovus Financial 7:30 a.m. May 30, 2014 - PR Newswire - PRF
AmpliPhi Announces Appointment of New Board Member 3:16 p.m. May 22, 2014 - BusinessWire - BZX
Biotech Equities Under Review -- Research on Achillion Pharma, Mast Therapeutics, Alkermes, and Momenta Pharma 12:30 p.m. May 9, 2014 - PR Newswire - PRF
Mast Therapeutics Reports First Quarter 2014 Financial Results 7:00 a.m. May 5, 2014 - PR Newswire - PRF
Biotech Stocks Review -- Research on Achillion Pharma, Medivation, Mast Therapeutics, and Athersys 7:16 a.m. April 14, 2014 - PR Newswire - PRF
Mast Therapeutics Announces New Data Supporting MST-188 In Sickle Cell Disease 7:00 a.m. April 14, 2014 - PR Newswire - PRF
Mast Therapeutics Reports Fourth Quarter And Full Year 2013 Financial Results 7:15 a.m. March 26, 2014 - PR Newswire - PRF
Mast Therapeutics Initiates Phase 2 Study Of MST-188 In Patients With Acute Limb Ischemia 7:00 a.m. March 26, 2014 - PR Newswire - PRF
Active Stocks Coverage -- Research on Starbucks, Gerdau, Mast Therapeutics and Cia de Saneamento Basico do Estado 9:28 a.m. March 21, 2014 - PR Newswire - PRF
Purified Poloxamer Granted Unique Nonproprietary Name (Vepoloxamer) By U.S. Adopted Names Council 7:00 a.m. March 11, 2014 - PR Newswire - PRF
Vista Partners Publishes March 2014 Macroeconomic & Investment Newsletter 9:01 a.m. March 7, 2014 - Marketwire
(0)
(0)